1. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond

   • Jeffrey E. Gershenwald
   • Richard A. Scolyer

   Melanomas 30 May 2018 Pages: 2105 - 2110

   

2. Crystal Ball or Magic8 Ball? Reply Hazy, Try Again

   • A. James O’Malley
   • Sandra L. Wong

   Melanomas 21 May 2018 Pages: 2111 - 2113

3. Global Forum of Cancer Surgeons: A Steady Voice for Cancer Surgeons to Improve Surgical Care for Cancer Patients Globally

   • Chandrakanth Are
   • Kelly M. McMasters
   • Augusto Leon Ramirez

   Health Services Research and Global Oncology 07 June 2018 Pages: 2114 - 2116

   

4. Strategic Delay: Histology- and Biology-Driven Decision-Making in Recurrent Retroperitoneal Sarcoma

   • Carol J. Swallow

   Bone and Soft Tissue Sarcomas 04 June 2018 Pages: 2117 - 2119

5. Clinical Complete Response After Neoadjuvant Therapy for Esophageal Cancer: What’s Lurking Under the Surface?

   • Lorenzo Ferri

   Thoracic Oncology 14 May 2018 Pages: 2120 - 2121

6. Walking the Fine Line of Axillary Management in Mastectomy Patients

   • Carla Suzanne Fisher

   Breast Oncology 24 April 2018 Pages: 2122 - 2123

7. Optimizing Surgical Management of the Axilla After Neoadjuvant Chemotherapy: An Evolving Story

   • Eleftherios P. Mamounas

   Breast Oncology 30 May 2018 Pages: 2124 - 2126

8. Future Treatment Strategy for Esophageal Cancer Based on Prediction of Systemic Recurrence: Significance of Pathologic Nodal Status After Neoadjuvant Chemotherapy

   • Takushi Yasuda

   Gastrointestinal Oncology 29 May 2018 Pages: 2127 - 2128

9. Minimally Invasive Surgery for Retroperitoneal Sarcoma: Just Because We Can Does Not Mean We Should

   • Alessandro Gronchi
   • Aimee Crago
   • Chandrajit P. Raut

   Bone and Soft Tissue Sarcomas 14 June 2018 Pages: 2129 - 2131

   

10. Current Management and Future Opportunities for Peritoneal Metastases

    • David L. Bartlett

    Gastrointestinal Oncology 08 June 2018 Pages: 2132 - 2134

11. Management of Mucinous Appendiceal Tumors

    • Haroon A. Choudry
    • Reetesh K. Pai

    Colorectal Cancer 01 May 2018 Pages: 2135 - 2144

    

12. Peritoneal Metastases in Colorectal Cancer

    • Richard Jacobson
    • Scott K. Sherman
    • Kiran K. Turaga

    Colorectal Cancer 10 May 2018 Pages: 2145 - 2151

    

13. Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    • Rebecca M. Dodson
    • Michael Kuncewitch
    • Edward A. Levine

    Gastrointestinal Oncology 31 January 2018 Pages: 2152 - 2158

    

14. Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma

    • H. Richard Alexander Jr.
    • Claire Yue Li
    • Timothy J. Kennedy

    Gastrointestinal Oncology 08 February 2018 Pages: 2159 - 2164

    

15. Palliative Management of Peritoneal Metastases

    • Laura A. Lambert
    • Jason Wiseman

    Gastrointestinal Oncology 30 January 2018 Pages: 2165 - 2171

    

16. Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors

    • Emily C. Zabor
    • Daniel Coit
    • Katherine S. Panageas

    Melanomas 22 February 2018 Pages: 2172 - 2177

    

17. Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience

    • Jin-soo Park
    • Kheng-Seong Ng
    • Christopher J. Young

    Melanomas 24 April 2018 Pages: 2178 - 2183

    

18. Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients

    • ChuanLiang Cui
    • Bin Lian
    • Jun Guo

    Melanomas 10 May 2018 Pages: 2184 - 2192

    

19. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit

    • Naruhiko Ikoma
    • Christina L. Roland
    • Barry W. Feig

    Bone and Soft Tissue Sarcomas 08 March 2018 Pages: 2193 - 2200

    

20. Long-Term Outcome After Surgery for a Localized Retroperitoneal Soft Tissue Sarcoma in Elderly Patients: Results from a Retrospective, Single-Center Study

    • I. Sourrouille
    • R. Macovei
    • C. Honoré

    Bone and Soft Tissue Sarcomas 24 May 2018 Pages: 2201 - 2208

    

21. Minimally Invasive Versus Open Primary Resection for Retroperitoneal Soft Tissue Sarcoma: A Propensity-Matched Study From the National Cancer Database

    • Faiz Gani
    • Utkarsh Goel
    • Fabian M. Johnston

    Bone and Soft Tissue Sarcomas 31 May 2018 Pages: 2209 - 2217

    

22. Totally Laparoscopic Transluminal Resection for Gastrointestinal Stromal Tumors Located at the Cardiac Region

    • Zejian Lyu
    • Zifeng Yang
    • Yong Li

    Gastrointestinal Oncology 06 June 2018 Pages: 2218 - 2219

23. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy

    • Sara Gaines
    • Nicholas Suss
    • Katharine Yao

    Breast Oncology 06 April 2018 Pages: 2220 - 2228

24. Surgical Management of Lobular Carcinoma In Situ: Analysis of the National Cancer Database

    • Lauren J. Taylor
    • Jennifer Steiman
    • Heather B. Neuman

    Breast Oncology 31 May 2018 Pages: 2229 - 2234

    

25. Evaluation of the Relationship Between Flap Tension and Tissue Perfusion in Implant-Based Breast Reconstruction Using Laser-Assisted Indocyanine Green Angiography

    • Chae-Eun Yang
    • Soon Won Chung
    • Seung Yong Song

    Breast Oncology 21 May 2018 Pages: 2235 - 2240

    

26. Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes

    • Brittany L. Murphy
    • Courtney N. Day
    • Judy C. Boughey

    Breast Oncology 21 May 2018 Pages: 2241 - 2248

    

27. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database

    • Cecilia T. Ong
    • Brittany M. Campbell
    • Oluwadamilola M. Fayanju

    Breast Oncology 31 May 2018 Pages: 2249 - 2260

    

28. RNA-Seq of Circulating Tumor Cells in Stage II–III Breast Cancer

    • Julie E. Lang
    • Alexander Ring
    • Daniel Campo

    Breast Oncology 04 June 2018 Pages: 2261 - 2270

    

29. Routine Axillary Ultrasound for Patients with T1–T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling

    • Jennifer Wellington
    • Thomas Sanders
    • Rubie Sue Jackson

    Breast Oncology 04 June 2018 Pages: 2271 - 2278

    

30. Inhibition Mechanism of Acellular Dermal Matrix on Capsule Formation in Expander–Implant Breast Reconstruction After Postmastectomy Radiotherapy

    • Il-Kug Kim
    • Seong Oh Park
    • Ung Sik Jin

    Breast Oncology 31 May 2018 Pages: 2279 - 2287

    

31. Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates

    • Jose G. Bazan
    • Lonika Majithia
    • Julia R. White

    Breast Oncology 18 June 2018 Pages: 2288 - 2295

    

32. Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States

    • Ariella M. Altman
    • Scott Kizy
    • Schelomo Marmor

    Breast Oncology 15 June 2018 Pages: 2296 - 2302

    

33. Positive Nipple Margin After Nipple-Sparing Mastectomy: An Alternative and Oncologically Safe Approach to Preserving the Nipple–Areolar Complex

    • Michelle L. Haslinger
    • Michael Sosin
    • Eleni A. Tousimis

    Breast Oncology 15 June 2018 Pages: 2303 - 2307

    

34. Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database

    • Paula Marincola Smith
    • Colleen M. Kiernan
    • Carmen C. Solórzano

    Endocrine Tumors 04 June 2018 Pages: 2308 - 2315

    

35. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study

    • Xiao Shi
    • Nai-Si Huang
    • Qing-Hai Ji

    Head and Neck Oncology 29 May 2018 Pages: 2316 - 2322

    

36. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer

    • Sumana Narayanan
    • Tsutomu Kawaguchi
    • Kazuaki Takabe

    Colorectal Cancer 16 May 2018 Pages: 2323 - 2331

    

37. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes

    • Adan Z. Becerra
    • Steven D. Wexner
    • Fergal J. Fleming

    Colorectal Cancer 30 May 2018 Pages: 2332 - 2339

    

38. Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis

    • Z. J. Lee
    • S. L. Chia
    • C. C. M. Teo

    Colorectal Cancer 08 June 2018 Pages: 2340 - 2346

    

39. Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC

    • Nina R. Sluiter
    • Koen P. Rovers
    • Jurriaan B. Tuynman

    Colorectal Cancer Open access 31 May 2018 Pages: 2347 - 2356

    

40. Long-Term Oncologic Outcomes of Laparoscopic Sentinel Node Navigation Surgery in Early Gastric Cancer: A Single-Center, Single-Arm, Phase II Trial

    • Do Joong Park
    • Young Suk Park
    • Hyung-Ho Kim

    Gastrointestinal Oncology 21 May 2018 Pages: 2357 - 2365

    

41. Compliance with an Enhanced Recovery After a Surgery Program for Patients Undergoing Gastrectomy for Gastric Carcinoma: A Phase 2 Study

    • Mi Ran Jung
    • Seong Yeob Ryu
    • Oh Jeong

    Gastrointestinal Oncology 22 May 2018 Pages: 2366 - 2373

    

42. Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer

    • Valentina Mengardo
    • Orla Mc Cormack
    • Giovanni de Manzoni

    Gastrointestinal Oncology 04 June 2018 Pages: 2374 - 2382

    

43. Development and External Validation of a Simplified Nomogram Predicting Individual Survival After R0 Resection for Gastric Cancer: An International, Multicenter Study

    • Zhi-Fang Zheng
    • Jun Lu
    • Chao-Hui Zheng

    GASTROINTESTINAL ONCOLOGY 07 June 2018 Pages: 2383 - 2390

    

44. Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix

    • Erica S. Tsang
    • Yarrow J. McConnell
    • Hagen F. Kennecke

    Gastrointestinal Oncology 18 June 2018 Pages: 2391 - 2399

    

45. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival

    • Joel M. Baumgartner
    • Victoria M. Raymond
    • Razelle Kurzrock

    Gastrointestinal Oncology 14 June 2018 Pages: 2400 - 2408

    

46. The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

    • Hiroshi Miyata
    • Koji Tanaka
    • Yuichiro Doki

    Gastrointestinal Oncology 10 May 2018 Pages: 2409 - 2417

    

47. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas

    • Ulrike Heger
    • Leila Sisic
    • Thomas Schmidt

    Gastrointestinal Oncology 31 May 2018 Pages: 2418 - 2427

    

48. Comparison of Outcome of Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer with Clinical Complete Response to Neoadjuvant Therapy

    • Yu Ohkura
    • Junichi Shindoh
    • Harushi Udagawa

    Gastrointestinal Oncology 21 March 2018 Pages: 2428 - 2433

    

49. Prophylaxis of Postoperative Venous Thromboembolism Using Enoxaparin After Esophagectomy: A Prospective Observational Study of Effectiveness and Safety

    • Naoya Yoshida
    • Yoshifumi Baba
    • Hideo Baba

    Gastrointestinal Oncology 06 June 2018 Pages: 2434 - 2440

    

50. Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)

    • Eelke Toxopeus
    • Maartje van der Schaaf
    • Bas Wijnhoven

    Gastrointestinal Oncology Open access 12 June 2018 Pages: 2441 - 2448